Home › Plexiform Neurofibroma
Plexiform Neurofibroma clinical trials recruiting in the U.S.
8 studies for Plexiform Neurofibroma are recruiting participants at sites across the United States.
Cities with the most studies
- Washington, DC7 studies
- Philadelphia, PA4 studies
- Birmingham, AL4 studies
- Dallas, TX3 studies
- Cincinnati, OH3 studies
By state
- Alabama4 studies
- District of Columbia4 studies
- Maryland6 studies
- Ohio3 studies
- Pennsylvania4 studies
- Texas3 studies
Recently updated studies
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Sep 22, 2026 · NCT02544022Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
RecruitingObservational study
Ages 3 to 120 · All sexes · Updated Sep 2, 2026 · NCT06222203Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
RecruitingPhase 1
Ages 3 to 35 · All sexes · Updated Aug 24, 2026 · NCT02390752Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Aug 24, 2026 · NCT06502171A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jul 29, 2026 · NCT06541847A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
Recruiting
Ages 1 to 120 · All sexes · Updated Jun 9, 2026 · NCT06507748Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RecruitingPhase 2
Ages 1 to 8 · All sexes · Updated May 29, 2026 · NCT06188741PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06961565From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.